This is a preview of subscription content, log in via an institution to check access.
Reference
Brill A. Lost Prescription Drug Savings from Use of REMS Programs to Delay Generic Market Entry. Internet Document : Jul 2014. Available from: URL: http://www.matrixglobaladvisors.com/storage/REMS_Study_July.pdf
Rights and permissions
About this article
Cite this article
$US billions lost annually from strategies to delay generics. PharmacoEcon Outcomes News 709, 2 (2014). https://doi.org/10.1007/s40274-014-1442-6
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1442-6